USPTO serial 99745236
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: November 25, 2026
The USPTO examiner has issued a descriptiveness refusal and requested an acceptable specimen showing your trademark in actual commercial use.
Hesperos, Inc.
Orlando, FL, US
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Pharmaceutical research and development; Pharmaceutical drug development services; Biotechnology research; Biochemical research and development; Research and development in the field of biomedicine | ACTIVE | Sep 1, 2015 |
| Date | Code | Event |
|---|---|---|
| Aug 25, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 25, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Aug 25, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Aug 14, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Aug 13, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 4, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Apr 4, 2026 | NWAP | NEW APPLICATION ENTERED |